Andrew Serafin

Andrew Serafin

EVP, Chief Strategy OfficeratHarmony Biosciences Holdings· In proxies 2021–2025

Pay in FY2025-4% from the year before · Harmony Biosciences Holdings stock +8.7% the same year

Andrew Serafin was paid $2.0M in FY2025 (Dec), down 4%. Harmony Biosciences Holdings stock rose 8.7% that year.

Pay$100 in the stock at the end of FY20 → $104
Pay is from the Summary Compensation Table of each Harmony Biosciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Harmony Biosciences HoldingsPublic company · 5 yr
    • EVP, Chief Strategy Officer2021 – Present · 5 yrStock in role +6%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?